Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia

Leukemia. 2022 Dec;36(12):2922-2926. doi: 10.1038/s41375-022-01733-8. Epub 2022 Oct 22.

Nieves Garcia-Gisbert^{1

2}, Leonor Arenillas^{3

4}, David Roman-Bravo^{3

4}, Juan Jose Rodriguez-Sevilla⁵, Concepción Fernández-Rodríguez^{1

6}, Sara Garcia-Avila^{1

5}, Patricia Velez^{1

5}, Joan Gibert^{1

6}, Lierni Fernández-Ibarrondo^{1

2}, Antonio Salar^{1

5}, Lourdes Florensa^{3

4}, Beatriz Bellosillo^{1

2

6}, Ana Ferrer^{3

4}, Xavier Calvo^{7

8}

¹ Group of Applied Clinical Research in Hematology, IMIM-Hospital del Mar, Barcelona, Spain.
² Pompeu Fabra University, Barcelona, Spain.
³ Group of Translational Research on Hematological Neoplasms, IMIM-Hospital del Mar, Barcelona, Spain.
⁴ Laboratori de Citologia Hematològica, Department of Pathology, Hospital del Mar, Barcelona, Spain.
⁵ Department of Hematology, Hospital del Mar, Barcelona, Spain.
⁶ Laboratory of Molecular Diagnostics, Pathology Department, Hospital del Mar, Barcelona, Spain.
⁷ Group of Translational Research on Hematological Neoplasms, IMIM-Hospital del Mar, Barcelona, Spain. xcalvo@psmar.cat.
⁸ Laboratori de Citologia Hematològica, Department of Pathology, Hospital del Mar, Barcelona, Spain. xcalvo@psmar.cat.

No abstract available

Publication types